1. Expression of mRNA for growth hormone-releasing hormone and splice variants of GHRH receptors in human malignant bone tumors
    R Busto et al, 2002, Regulatory Peptides CrossRef
  2. Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin
    C. A. Kanashiro et al, 2003, Proceedings of the National Academy of Sciences CrossRef
  3. null
    Hippokratis Kiaris et al, 2005 CrossRef
  4. Antagonists of growth hormone releasing hormone and bombesin inhibit the expression of EGF/HER receptor family in H-69 small cell lung carcinoma
    Celia A. Kanashiro et al, 2005, Cancer Letters CrossRef
  5. Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel
    F. Hohla et al, 2006, Proceedings of the National Academy of Sciences CrossRef
  6. Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel
    S. Buchholz et al, 2007, Proceedings of the National Academy of Sciences CrossRef
  7. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer
    Andrew V Schally et al, 2008, Nat Rev Endocrinol CrossRef
  8. New analogs of human growth hormone-releasing hormone (1-29) with high and prolonged antagonistic activity
    KATALIN TOTH et al, 2009 CrossRef
  9. null
    A. V. Schally, 2003 CrossRef
  10. Synthesis of Potent Antagonists of Receptors for Growth Hormone-Releasing Hormone with High Antitumor and Anti-inflammatory Activity
    Renzhi Cai et al, 2021, Peptides CrossRef
  11. GHRH antagonist inhibits focal adhesion kinase (FAK) and decreases expression of vascular endothelial growth factor (VEGF) in human lung cancer cells in vitro
    Agnieszka Siejka et al, 2012, Peptides CrossRef
  12. The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas
    Rebeca Busto et al, 2002, Proc. Natl. Acad. Sci. U.S.A. CrossRef
  13. Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone
    Gabor Halmos et al, 2000, Proc. Natl. Acad. Sci. U.S.A. CrossRef
  14. Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs
    Hippokratis Kiaris et al, 2002, Proc. Natl. Acad. Sci. U.S.A. CrossRef
  15. Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone
    Hippokratis Kiaris et al, 1999, Proc. Natl. Acad. Sci. U.S.A. CrossRef
  16. Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma
    Andreas Jungwirth et al, 1997, Proc. Natl. Acad. Sci. U.S.A. CrossRef
  17. Antitumorigenic actions of growth hormone-releasing hormone antagonists
    Rhonda D. Kineman, 2000, Proc. Natl. Acad. Sci. U.S.A. CrossRef
  18. Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities
    József L. Varga et al, 1999, Proc. Natl. Acad. Sci. U.S.A. CrossRef
  19. Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors
    Najib Lamharzi et al, 1998, Proc. Natl. Acad. Sci. U.S.A. CrossRef
  20. Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro
    Valér J. Csernus et al, 1999, Proc. Natl. Acad. Sci. U.S.A. CrossRef
  21. Growth hormone-releasing hormone: An autocrine growth factor for small cell lung carcinoma
    H. Kiaris et al, 1999, Proc. Natl. Acad. Sci. U.S.A. CrossRef
  22. Antagonists of Growth Hormone-Releasing Hormone and Somatostatin Analog RC-160 Inhibit the Growth of the OV-1063 Human Epithelial Ovarian Cancer Cell Line Xenografted into Nude Mice1
    Ioulia Chatzistamou et al, 2001 CrossRef
  23. Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in Primary Human Endometrial Carcinomas: Novel Therapeutic Approaches
    Zsuzsanna Szabo et al, 2022, Molecules CrossRef
  24. Targeting luteinizing hormone-releasing hormone: A potential therapeutics to treat gynecological and other cancers
    Raksha Ghanghoria et al, 2016, Journal of Controlled Release CrossRef
  25. Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth
    Marta Zarandi et al, 2017, Peptides CrossRef
  26. The effects of a growth hormone-releasing hormone antagonist and a gastrin-releasing peptide antagonist on intimal hyperplasia of the carotid artery after balloon injury in a diabetic rat model☆
    John C. Moscona et al, 2017, ARTRES CrossRef
  27. Inhibition of experimental small-cell and non-small-cell lung cancers by novel antagonists of growth hormone-releasing hormone.
    Haibo Wang et al, 2018, Int J Cancer CrossRef
  28. Growth hormone-releasing hormone (GHRH) and its agonists inhibit hepatic and tumoral secretion of IGF-1
    Tengjiao Cui et al, 2018, Oncotarget CrossRef
  29. Hypothalamic Hormones and Cancer
    Andrew V. Schally et al, 2001, Frontiers in Neuroendocrinology CrossRef
  30. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours.
    null Szepeshazi et al, 0 CrossRef
  31. Direct action of growth hormone-releasing hormone agonist JI-38 on normal human fibroblasts: Evidence from studies on cell proliferation and c-myc proto-oncogene expression
    Hippokratis Kiaris et al, 2001, Regulatory Peptides CrossRef
  32. Synthesis and In Vitro Evaluation of New Potent Antagonists of Growth Hormone-Releasing Hormone (GH-RH)
    Marta Zarandi et al, 1997, Peptides CrossRef
  33. Antagonistic analogs of growth hormone releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro☆
    Valér Csernus et al, 1999, Peptides CrossRef
  34. Inhibition of GH Release in Rats by New Potent Antagonists of Growth Hormone-Releasing Hormone (GH-RH)
    Magdolna Kovács et al, 1997, Peptides CrossRef
  35. Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents
    Andrew V Schally et al, 1999, Trends in Endocrinology & Metabolism CrossRef
  36. Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of U-87MG Human Glioblastoma in Nude Mice
    Hippokratis Kiaris et al, 2000, Neoplasia CrossRef
  37. Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice
    Zsuzsanna Kahán et al, 2000, Breast Cancer Res Treat CrossRef
  38. Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone
    Ioulia Chatzistamou et al, 2001, Anti-Cancer Drugs CrossRef
  39. GHRH and the prostate
    Laura Muñoz-Moreno et al, 2024, Rev Endocr Metab Disord CrossRef